Evidence map›Paper›PMID 41753241›Full record

ArticleJournal of clinical medicine2026

Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study.

Mehmet Cihan İcli, Deniz Can Guven, Arif Akyildiz, Ali Fuat Gürbüz, Nargiz Majidova, Mehmet Mutlu Kıdı, Hakan Kosku, Elif Sahin, Tugce Kubra Gunes, Mustafa Seyyar and 7 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mehmet Cihan İcliDepartment of Medical Oncology, Hacettepe University, Ankara 06100, Türkiye.ORCID 0000-0002-7857-6902
Deniz Can GuvenDepartment of Medical Oncology, Hacettepe University, Ankara 06100, Türkiye.ORCID 0000-0002-6924-9467
Arif AkyildizDepartment of Medical Oncology, Hacettepe University, Ankara 06100, Türkiye.ORCID 0000-0002-4452-2076
Ali Fuat GürbüzDepartment of Oncology, Necmettin Erbakan University, Konya 42090, Türkiye.ORCID 0000-0003-1455-471X
Nargiz MajidovaDepartment of Oncology, VM Medical Park Maltepe Hospital, Istanbul 34846, Türkiye.ORCID 0000-0002-2575-5819
Mehmet Mutlu KıdıDepartment of Oncology, Cukurova University, Adana 01330, Türkiye.
Hakan KoskuDepartment of Oncology, Bilkent City Hospital, Ankara 06800, Türkiye.
Elif SahinDepartment of Oncology, Kocaeli City Hospital, Kocaeli 41060, Türkiye.ORCID 0000-0002-1976-3951
Tugce Kubra GunesDepartment of Oncology, Umraniye Training and Research Hospital, Istanbul 34764, Türkiye.
Mustafa SeyyarDepartment of Oncology, Gaziantep City Hospital, Gaziantep 27470, Türkiye.ORCID 0000-0002-4841-7994
Elvina AlmuradovaDepartment of Oncology, Memorial Goztepe Hospital, Istanbul 34634, Türkiye.
Pervin Can SancıBakırçay University Çiğli Training and Research Hospital, İzmir 35620, Türkiye.
Burak BilginDepartment of Oncology, Bilkent City Hospital, Ankara 06800, Türkiye.
Ismail Oguz KaraDepartment of Oncology, Cukurova University, Adana 01330, Türkiye.
Mehmet ArtacDepartment of Oncology, Necmettin Erbakan University, Konya 42090, Türkiye.
Ömer DizdarDepartment of Medical Oncology, Hacettepe University, Ankara 06100, Türkiye.
Suayib YalcinDepartment of Medical Oncology, Hacettepe University, Ankara 06100, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immunotherapy 2MSI-H colorectal cancer 1overall survival 3progression-free survival

Identifiers

PMID41753241
PMCPMC12942511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.